Calendario›OCUL›Artificial Tears

Artificial Tears

An Observational, Qualitative Study Assessing Eye Drop Administration

Ensayo de OCULAR THERAPEUTIX, INC en Ocular Injury (del registro, en inglés).

Fase

no aplica

Estado

Sin noticias del promotor

Participantes

300

previstos

Centros

1

Fin del objetivo primario

jul 2023

estimado por el promotor

Qué significa cada fase y cada estado.

Estudio observacional. Comenzó en abr 2022.

Qué mide

Proportion of patients who meet pre-specified "success" criteria for proper administration of eye drop onto ocular surface on first attempt session as evaluated by the ophthalmologist or optometrist grader (There will be a total of three eye drop administration attempts - Two attempts occur on the first visit (Day 0)) (del registro, en inglés)

Cómo lo describe el promotor

En el documentoEn inglés, del registroThis is a prospective, observational, consecutive, qualitative, multicenter study. Based on the available published evidence that supports patient challenges with eyedrop administration, the purpose of this video-capture study is to evaluate a more real-world population of consenting patients, regardless of age, with or without visual impairment, at routine eyecare visits. To date, no studies have been performed evaluating a real-world population consisting of daily routine eyecare clinic patients with or without visual impairment. This study will help to determine the ability to achieve success with self-administration of eyedrops in the real world.

Más ensayos de OCUL

Todos los de OCUL, en su ficha.

Ficha completa en ClinicalTrials.gov (NCT05307081), actualizada en sep 2022.